Outcomes of Treatment for Melanoma Brain Metastases

Table 8

Survival results of the patients treated by systemic therapy.

Group	Number of patients	1-year survival	2-year survival	5-year survival
Systemic therapy	16 (32%)	82.3% [64.9; 91.7]	58.8% [40.6; 73.2]	27.3% [13.2; 43.5]
No systemic therapy	34 (68%)	75.0% [46.3; 89.8]	43.8% [19.8; 65.6]	7.8% [0.0; 29.1]